Be the cure
Be the cure
Be the
Change a life
Change a life
Change a
Join our team
Join our team
Join our

The expertise to create cures and life-changing treatments

Assembly Bio is passionately applying scientific ingenuity and a deep knowledge of virology to find a cure for hepatitis B (HBV) infection, one of the world’s most prevalent and devastating infectious diseases, and to discover novel antivirals to treat serious viral diseases. Be a part of our ambitious and caring life’s work. Together, we have the potential to change lives.

In the News
February 15, 2023
Assembly Biosciences Nominates First Herpesvirus Development Candidate ABI-5366, a Long-Acting HSV-2 Helicase Inhibitor Targeting High-Recurrence Genital Herpes
December 19, 2022
Assembly Biosciences Announces Promising Interim Results from Two Clinical Trials Evaluating Highly Potent Next-Generation Core Inhibitor Candidates ABI-H3733 and ABI-4334
November 14, 2022
Assembly Biosciences Doses First Subject in Phase 1a Clinical Trial to Evaluate Safety, Tolerability and Pharmacokinetic Profile of Investigational Next Generation Core Inhibitor ABI-4334
    Be the cure

    “It’s time to end the deadly Hepatitis B virus that has killed more than 800,000 people a year, including my own family members. I’m encouraged by the efforts of Assembly Bio to develop better treatments that could lead to a cure.”

    — Alan Wang, Emmy award-winning television news anchor.
    Infected at birth with chronic Hepatitis B.

    Change a life

    “As a resident in Anesthesiology and Intensive Care, I’ve seen patients die of the consequences of hepatitis B, and I can see that it has a devasting impact on people in every country around the world. Now is the time to cure hepatitis B and save over 800,000 unnecessary deaths every year. I am grateful for the support and partnership of Assembly Bio in our shared goal of eradicating hepatitis B once and for all.”

    — Dr Hélène Drouin, Resident in Anesthesiology and Intensive Care,
    future Mount Everest climber